Despite advantages of bodily exercise, the extent of bodily exercise shouldn’t be fascinating in sufferers with sort 2 diabetes. The purpose of this research is the utilizing of integration of intervention primarily based on the speculation of safety motivation and implementation intention so as to enhance the extent of exercise in sufferers with diabetes.
This discipline trial research has been carried out on 125 sufferers with sort 2 diabetes. Samples have been randomly chosen, and they’re divided into two intervention and management teams. In the intervention group, coaching classes have been performed primarily based on the safety motivation principle and implementation intention.
Physical exercise ranges, VO2 max, and hemoglobin A1C have been measured earlier than and three months after the intervention within the two teams. Data have been analyzed through the use of SPSS 18, and impartial t-test, paired t-test, and equal nonparametric exams have been used for analyzing irregular information. The outcomes of this research confirmed that the extent of bodily exercise was increased within the intervention group (p = 0.02).
Also, the quantity of hemoglobin A1c within the intervention group has been decreased considerably three months later (p < 0.001). In this research, VO2 max and blood lipids weren’t considerably completely different within the two teams. However, there was increased VO2 max in contrast to earlier than the intervention within the intervention group.
The current research confirmed that combining motivational interventions and implementing intention intervention could be efficient in selling the bodily exercise of sufferers with sort 2 diabetes.
Association between sort 2 diabetes and osteoporosis danger: A consultant cohort research in Taiwan
Although earlier research have investigated the connection between fracture danger and sort 2 diabetes (T2D), cohort research that estimate composite osteoporosis danger are missing. This retrospective cohort research sought to decide the danger of osteoporosis in Taiwanese sufferers with T2D. Patients recognized with T2D between 2002 and 2015 recognized via the 2002 Taiwan Survey of Hypertension, Hyperglycemia, and Hyperlipidemia have been included.
A complete of 1690 males and 1641 girls aged ≥40 years linked to the National Health Insurance Research Database (NHIRD) have been adopted up to the tip of 2015 to determine the incidences of osteoporosis via ICD9-CM codes for osteoporosis or osteoporotic fractures or utilization of anti-osteoporotic brokers in accordance to Anatomical Therapeutic Chemical codes decided from NHIRD.
The particular person 12 months strategy and Kaplan-Meier evaluation have been then used to estimate the incidences and cumulative occasion charges, whereas the Cox proportional hazard mannequin was used to calculate adjusted hazard ratios (HR) for osteoporosis occasions.
A complete of 792 new osteoporosis occasions have been documented over a median follow-up period of 13.6 years. Participants with T2D had increased osteoporosis danger [adjusted HR: 1.37, 95% confidence interval (CI): 1.11-1.69] in contrast with these with out T2D. Subgroup analyses revealed that age had a slightly vital impact, indicating that T2D had a extra pronounced impact on osteoporosis danger in youthful inhabitants (<65 years outdated).
No distinction was discovered between sufferers stratified in accordance to intercourse. In conclusion, T2D was considerably related with elevated osteoporosis danger, particularly in youthful individuals.

Predictive Factors and Amputation Level for Reamputation in Patients With Diabetic Foot: A Retrospective Case-Control Study
The purpose of this research was to assess the speed and stage of reamputation in sufferers who had a earlier amputation from diabetic foot. We retrospectively analyzed sufferers who underwent amputation and reamputation due to diabetic foot in our clinic between 2011 and 2019. Fifty-nine have been evaluated because the healed group after the primary amputation and 55 have been evaluated because the reamputation group. Given 55 sufferers who wanted reamputation: there have been 13 finger or ray, 23 transmetatarsal or syme, 18 transtibial, and 1 transfemoral within the first operation. We discovered the reamputation price was 65.4% in distal amputations.
When serum parameters have been examined earlier than the primary amputation in every group, there was no statistically vital distinction in white blood cells, neutrophils, lymphocytes, platelets, sedimentation, C-reactive protein, complete protein, hematocrit, urea, creatinine, and HgA1c values.
There was, nevertheless, a big distinction between teams in albumin ranges. When comorbidities have been assessed for smoking, hypertension, period of diabetes, and quantity of debridements after the primary surgical procedure, a big distinction between teams was discovered.
When peripheral artery illness and continual renal failure have been examined, no vital distinction was noticed. In our research, it was noticed that the speed of reamputation was increased in distal stage amputations for diabetic foot sufferers. Accordingly, albumin values, smoking, hypertension, period of diabetes, quantity of debridements after surgical procedure, have been seen as danger components for reamputation sufferers.
National developments within the prevalence of glycemic management amongst sufferers with sort 2 diabetes receiving steady care in Thailand from 2011 to 2018
Diabetes is one of the most important international well being issues and reveals a continuously growing development. A collection of nationwide hospital-based cross-sectional surveys of medical outcomes was carried out yearly from 2011 to 2015 and 2018 amongst sufferers with sort 2 diabetes aged ≥ 20 years receiving medical look after no less than 12 months.
A two-stage stratified cluster that was proportional to the dimensions sampling method was used to choose a nationally and provincially consultant pattern of sufferers with sort 2 diabetes in Thailand. A complete of 186,010 sufferers with sort 2 diabetes have been enrolled within the research from 2011 to 2018. The prevalence of satisfactory glycemic management (hemoglobinA1c stage < 7.0%) amongst sufferers with sort 2 diabetes have been estimated to be 34.5% (95%CI 33.8-35.2%) in 2011, 33.0% (95%CI 32.4-33.6%) in 2012, 34.7% (95%CI 34.1-35.4%) in 2013, 35.5 (95%CI 34.9-36.1%) in 2014, 35.6 (95%CI 35.0-36.2%) in 2015, and 35.6% (95%CI 35.0-36.2%) in 2018, respectively (p for development < 0.001).
Gene Knock-Out HR Targeting Vector [MCS1-EF1a-RFP-T2A-Hygro-pA-MCS2] |
|||
HR510PA-1 | SBI | 10 ug | 1227.6 EUR |
TARGATT? Knock-in iPSC Generation (Master Cell Line) |
|||
AST-1100 | Applied StemCell | 1 vial of 1X10^6 cells | Ask for price |
Description: 6 month |
|||
TARGATT? Knock-in Mouse Cell Line Generation Kit (Master Cell Line) |
|||
AST-7001 | Applied StemCell | 1 Kit | Ask for price |
Description: 6 month |
|||
Rrad/ Rat Rrad ELISA Kit |
|||
ELI-14921r | Lifescience Market | 96 Tests | 1063.2 EUR |
Rrad 3'UTR GFP Stable Cell Line |
|||
TU269725 | ABM | 1.0 ml | Ask for price |
RRAD 3'UTR Luciferase Stable Cell Line |
|||
TU022380 | ABM | 1.0 ml | 1672.8 EUR |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
TU219725 | ABM | 1.0 ml | Ask for price |
RRAD 3'UTR GFP Stable Cell Line |
|||
TU072380 | ABM | 1.0 ml | 1672.8 EUR |
Rrad 3'UTR GFP Stable Cell Line |
|||
TU168183 | ABM | 1.0 ml | Ask for price |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
TU118183 | ABM | 1.0 ml | Ask for price |
TARGATT? Knock-in CHO Generation Kit (Master Cell Line) |
|||
AST-1200 | Applied StemCell | 1 Kit | Ask for price |
Description: 12 month |
|||
TARGATT? Knock-in HEK293 Generation Kit (Master Cell Line) |
|||
AST-1300 | Applied StemCell | 1 Kit | Ask for price |
Description: 12 month |
|||
RRAD Peptide |
|||
43-008P | ProSci | 0.1 mg | 405.6 EUR |
Description: RRAD Peptide |
|||
RRAD antibody |
|||
70R-50359 | Fitzgerald | 100 ul | 292.8 EUR |
Description: Purified Polyclonal RRAD antibody |
|||
RRAD antibody |
|||
70R-5797 | Fitzgerald | 50 ug | 560.4 EUR |
Description: Rabbit polyclonal RRAD antibody raised against the middle region of RRAD |
|||
RRAD antibody |
|||
70R-5798 | Fitzgerald | 50 ug | 560.4 EUR |
Description: Rabbit polyclonal RRAD antibody raised against the middle region of RRAD |
|||
RRAD Antibody |
|||
37229-100ul | SAB | 100ul | 302.4 EUR |
RRAD Antibody |
|||
1-CSB-PA779820 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
|||
RRAD siRNA |
|||
20-abx932133 | Abbexa |
|
|
RRAD Antibody |
|||
CSB-PA233809-100ul | Cusabio | 100ul | 379.2 EUR |
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
RRAD Antibody |
|||
1-CSB-PA248209 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
|||
RRAD Antibody |
|||
1-CSB-PA003910 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000 |
|||
RRAD Antibody |
|||
R34275-100UG | NSJ Bioreagents | 100 ug | 399 EUR |
RRAD Antibody |
|||
CSB-PA233809- | Cusabio | each | 402 EUR |
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
Human K562 (Chronic Myelogenous Leukemia) lysate |
|||
HCL-1204 | Alpha Diagnostics | 1 mg | 628.8 EUR |
RRAD sgRNA CRISPR Lentivector set (Human) |
|||
K2069901 | ABM | 3 x 1.0 ug | 406.8 EUR |
Basic HR Targeting Vector [MCS1-LoxP-MCS2-MCS3-pA-LoxP-MCS4] for Gene Knock-In/Out |
|||
HR100PA-1 | SBI | 10 ug | 1125.6 EUR |
Human RRAD shRNA Plasmid |
|||
20-abx954199 | Abbexa |
|
|
RRAD ELISA KIT|Human |
|||
EF005507 | Lifescience Market | 96 Tests | 826.8 EUR |
RRAD Recombinant Protein (Human) |
|||
RP095493 | ABM | 100 ug | Ask for price |
RRAD sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K2069902 | ABM | 1.0 ug DNA | 184.8 EUR |
RRAD sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K2069903 | ABM | 1.0 ug DNA | 184.8 EUR |
RRAD sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K2069904 | ABM | 1.0 ug DNA | 184.8 EUR |
RRAD Blocking Peptide |
|||
33R-10070 | Fitzgerald | 100 ug | 216 EUR |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798 |
|||
RRAD Blocking Peptide |
|||
33R-4793 | Fitzgerald | 100 ug | 216 EUR |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797 |
|||
RRAD Blocking Peptide |
|||
20-abx063234 | Abbexa |
|
|
Polyclonal RRAD Antibody |
|||
APR05556G | Leading Biology | 0.1ml | 580.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications: |
|||
RRAD Conjugated Antibody |
|||
C37229 | SAB | 100ul | 476.4 EUR |
RRAD ORF Vector (Human) (pORF) |
|||
ORF031832 | ABM | 1.0 ug DNA | 486 EUR |
Gene Knock-Out HR Targeting Vector w/Single Selection Marker (Blasticidin) and Negative Selection (TK) Against Random Integration |
|||
HR720PA-1 | SBI | 10 µg | 1374 EUR |
293AAV Cell Line |
|||
AAV-100 | Cell Biolabs | 1 vial | 609.6 EUR |
Description: The 293AAV Cell Line is derived from the parental 293 cells but selected for attributes that increase AAV production, including firmer attachment and larger surface area. |
|||
293AD Cell Line |
|||
AD-100 | Cell Biolabs | 1 vial | 553.2 EUR |
Description: The 293AD Cell Line is derived from the parental 293 cells but selected for attributes that increase adenovirus production, including firmer attachment and larger surface area. |
|||
293LTV Cell Line |
|||
LTV-100 | Cell Biolabs | 1 vial | 609.6 EUR |
Description: The 293LTV Cell Line is derived from the parental 293 cells but selected for attributes that increase lentiviral production, including fimrer attachment and larger surface area. |
|||
293RTV Cell Line |
|||
RV-100 | Cell Biolabs | 1 vial | 609.6 EUR |
Description: The 293RTV Cell Line is derived from the parental 293 cells but selected for attributes that increase retroviral production, including fimrer attachment and larger surface area. |
|||
Rrad sgRNA CRISPR Lentivector set (Rat) |
|||
K7052701 | ABM | 3 x 1.0 ug | 406.8 EUR |
Rrad sgRNA CRISPR Lentivector set (Mouse) |
|||
K3480701 | ABM | 3 x 1.0 ug | 406.8 EUR |
PicoProbe? 15-PGDH Activity Assay Kit (Fluorometric) |
|||
K562-100 | Biovision | each | 639.6 EUR |
Gene Knock-Out HR Targeting Vector w/Dual Selection Markers (GFP+Puro) and Negative Selection (TK) Against Random Integration |
|||
HR700PA-1 | SBI | 10 µg | 1374 EUR |
Gene Knock-Out HR Targeting Vector w/Dual Selection Markers (RFP+Hygro) and Negative Selection (TK) Against Random Integration |
|||
HR710PA-1 | SBI | 10 µg | 1374 EUR |
293/GFP Cell Line |
|||
AKR-200 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: 293/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
T47D/GFP Cell Line |
|||
AKR-208 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
A549/GFP Cell Line |
|||
AKR-209 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: A549/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
HeLa/GFP Cell Line |
|||
AKR-213 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: HeLa/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
NIH3T3/GFP Cell Line |
|||
AKR-214 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: NIH3T3/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
NIH3T3/Cas9 Cell Line |
|||
AKR-5104 | Cell Biolabs | 1 vial | 686.4 EUR |
293/Cas9 Cell Line |
|||
AKR-5110 | Cell Biolabs | 1 vial | 686.4 EUR |
HeLa/Cas9 Cell Line |
|||
AKR-5111 | Cell Biolabs | 1 vial | 686.4 EUR |
TARGATT? Knock-in iPSC Genotyping Kit |
|||
AST-1102 | Applied StemCell | 1 Kit | Ask for price |
Description: 12 month |
|||
RRAD Recombinant Protein (Rat) |
|||
RP226925 | ABM | 100 ug | Ask for price |
RRAD Recombinant Protein (Mouse) |
|||
RP169340 | ABM | 100 ug | Ask for price |
Microplate Swing-Out Centrifuge |
|||
abx725026-1Unit | Abbexa | 1 Unit | 1771.2 EUR |
Clinical Swing-Out Centrifuge |
|||
abx725027-1Unit | Abbexa | 1 Unit | 1771.2 EUR |
Gene Knock-Out HR Targeting Vector with TK selection [MCS1-LoxP-EF1?-GFP-T2A-Puro-P2A-hsvTK-pA-LoxP-MCS2] |
|||
HR210PA-1 | SBI | 10 ug | 1374 EUR |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K7052702 | ABM | 1.0 ug DNA | 184.8 EUR |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K7052703 | ABM | 1.0 ug DNA | 184.8 EUR |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K7052704 | ABM | 1.0 ug DNA | 184.8 EUR |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K3480702 | ABM | 1.0 ug DNA | 184.8 EUR |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K3480703 | ABM | 1.0 ug DNA | 184.8 EUR |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K3480704 | ABM | 1.0 ug DNA | 184.8 EUR |
SKOV-3/Luc Cell Line |
|||
AKR-232 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
MCF-7/Luc Cell Line |
|||
AKR-234 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
OVCAR-5/RFP Cell Line |
|||
AKR-254 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
TARGATT? Knock-in iPSC Quick Knockin Kit |
|||
AST-1101 | Applied StemCell | 1 Kit | Ask for price |
Description: 12 month |
|||
Rrad ORF Vector (Rat) (pORF) |
|||
ORF075643 | ABM | 1.0 ug DNA | 607.2 EUR |
Rrad ORF Vector (Mouse) (pORF) |
|||
ORF056448 | ABM | 1.0 ug DNA | 607.2 EUR |
Anti-RRAD (aa36-48) antibody |
|||
STJ72757 | St John's Laboratory | 100 µg | 430.8 EUR |
RRAD Protein Vector (Human) (pPB-C-His) |
|||
PV127326 | ABM | 500 ng | 662.4 EUR |
RRAD Protein Vector (Human) (pPB-N-His) |
|||
PV127327 | ABM | 500 ng | 662.4 EUR |
RRAD Protein Vector (Human) (pPM-C-HA) |
|||
PV127328 | ABM | 500 ng | 662.4 EUR |
RRAD Protein Vector (Human) (pPM-C-His) |
|||
PV127329 | ABM | 500 ng | 662.4 EUR |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K2069905 | ABM | 3 x 1.0 ug | 451.2 EUR |
Swing-out rotor 6-place |
|||
CEN0179 | Scientific Laboratory Supplies | EACH | 607.62 EUR |
Swing-out rotor 8-place |
|||
CEN0180 | Scientific Laboratory Supplies | EACH | 701.1 EUR |
Swing-out rotor 12-place |
|||
CEN0181 | Scientific Laboratory Supplies | EACH | 531.24 EUR |
Rotor Swing out 6x5ml RB |
|||
CEN2634 | Scientific Laboratory Supplies | EACH | 429.78 EUR |
Rotor Swing out 2x3MTP ID |
|||
CEN2664 | Scientific Laboratory Supplies | EACH | 1299.6 EUR |
Autoclave Print-Out PAPER CR70 |
|||
SXP374 | Scientific Laboratory Supplies | EACH | 40.7 EUR |
Platinum-E Retroviral Packaging Cell Line, Ecotropic |
|||
RV-101 | Cell Biolabs | 1 vial | 1104 EUR |
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-E cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
|||
Platinum-A Retroviral Packaging Cell Line, Amphotropic |
|||
RV-102 | Cell Biolabs | 1 vial | 1104 EUR |
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-A cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
|||
Platinum-GP Retroviral Packaging Cell Line, Pantropic |
|||
RV-103 | Cell Biolabs | 1 vial | 1104 EUR |
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-GP cells contain the gag and pol genes required for retroviral packaging; an expression vector is co-transfected with a VSVG envelope vector. |
|||
Total Protein - Murine Embryonic Stem Cell Line D3 |
|||
CBA-305 | Cell Biolabs | 500 ?g | 414 EUR |
Description:
|
|||
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K2069906 | ABM | 1.0 ug DNA | 200.4 EUR |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K2069907 | ABM | 1.0 ug DNA | 200.4 EUR |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K2069908 | ABM | 1.0 ug DNA | 200.4 EUR |
Human GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx385354-96tests | Abbexa | 96 tests | 1093.2 EUR |
Human GTP- binding protein RAD, RRAD ELISA KIT |
|||
ELI-35549h | Lifescience Market | 96 Tests | 988.8 EUR |
GTP-Binding Protein RAD (RRAD) Antibody |
|||
20-abx008742 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
abx332370-100ul | Abbexa | 100 ul | 510 EUR |
GTP-binding protein RAD (RRAD) Antibody |
|||
20-abx241706 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
20-abx324872 | Abbexa |
|
|
GTP-Binding Protein RAD (RRAD) Antibody |
|||
abx432011-200ul | Abbexa | 200 ul | 460.8 EUR |
GTP-binding protein RAD (RRAD) Antibody |
|||
20-abx214509 | Abbexa |
|
|
Pipette Blow Out Milk 0.5-1ml |
|||
DAI2804 | Scientific Laboratory Supplies | EACH | 6.27 EUR |
Hettich 4 Place Swing Out Rotor |
|||
GBA5699 | Scientific Laboratory Supplies | EACH | 1984.74 EUR |
Swing out rotor 4 x microplates |
|||
CEN0148 | Scientific Laboratory Supplies | EACH | 1075.02 EUR |
Hettich Swing Out Rotor 2 Place |
|||
CEN0353 | Scientific Laboratory Supplies | EACH | 899.46 EUR |
Hettich Swing Out Rotor 4 Place |
|||
CEN0407 | Scientific Laboratory Supplies | EACH | 727.32 EUR |
Rotor Swing out 4x100mL ID Seal |
|||
CEN2680 | Scientific Laboratory Supplies | EACH | 752.4 EUR |
Hettich Swing Out Rotor 4 Place |
|||
CEN5014 | Scientific Laboratory Supplies | EACH | 1519.62 EUR |
Hettich Swing Out Rotor 2 Place |
|||
CEN5020 | Scientific Laboratory Supplies | EACH | 1143.42 EUR |
Hettich Swing Out Rotor 4 Place |
|||
CEN5034 | Scientific Laboratory Supplies | EACH | 1493.4 EUR |
Microtube 0.5mL Conical w/out Cap |
|||
TUB1084 | Scientific Laboratory Supplies | PK3000 | 96.9 EUR |
Microtube 1.5mL Conical w/out Cap |
|||
TUB1088 | Scientific Laboratory Supplies | PK3000 | 118.56 EUR |
Microtube 2mL Conical w/out Cap |
|||
TUB1092 | Scientific Laboratory Supplies | PK3000 | 118.56 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K7052705 | ABM | 3 x 1.0 ug | 451.2 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K3480705 | ABM | 3 x 1.0 ug | 451.2 EUR |
Polyclonal RRAD (aa36-48) Antibody (internal region) |
|||
APG00807G | Leading Biology | 0.1mg | 580.8 EUR |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human RRAD (aa36-48) (internal region). This antibody is tested and proven to work in the following applications: |
|||
RRAD Protein Vector (Mouse) (pPB-C-His) |
|||
PV225790 | ABM | 500 ng | 723.6 EUR |
RRAD Protein Vector (Mouse) (pPB-N-His) |
|||
PV225791 | ABM | 500 ng | 723.6 EUR |
RRAD Protein Vector (Mouse) (pPM-C-HA) |
|||
PV225792 | ABM | 500 ng | 723.6 EUR |
RRAD Protein Vector (Mouse) (pPM-C-His) |
|||
PV225793 | ABM | 500 ng | 723.6 EUR |
RRAD Protein Vector (Rat) (pPB-C-His) |
|||
PV302570 | ABM | 500 ng | 723.6 EUR |
RRAD Protein Vector (Rat) (pPB-N-His) |
|||
PV302571 | ABM | 500 ng | 723.6 EUR |
RRAD Protein Vector (Rat) (pPM-C-HA) |
|||
PV302572 | ABM | 500 ng | 723.6 EUR |
RRAD Protein Vector (Rat) (pPM-C-His) |
|||
PV302573 | ABM | 500 ng | 723.6 EUR |
Out At First Protein Homolog (OAF) Antibody |
|||
abx146027-100ug | Abbexa | 100 ug | 469.2 EUR |
Out At First Protein Homolog (OAF) Antibody |
|||
abx027798-400ul | Abbexa | 400 ul | 627.6 EUR |
Out At First Protein Homolog (OAF) Antibody |
|||
abx027798-80l | Abbexa | 80 µl | 343.2 EUR |
Hettich Swing Out Rotor 4 x 100ml |
|||
CEN0410 | Scientific Laboratory Supplies | EACH | 493.62 EUR |
Hettich Rotor Swing Out 6 x 250ml |
|||
CEN0706 | Scientific Laboratory Supplies | EACH | 1730.52 EUR |
Rotor Swing out 4 x 250mL ID |
|||
CEN2676 | Scientific Laboratory Supplies | EACH | 1077.3 EUR |
Rotor Swing out 4 x 100mL ID |
|||
CEN2678 | Scientific Laboratory Supplies | EACH | 894.9 EUR |
Rotor Swing out 16 x 50mL ID |
|||
CEN2688 | Scientific Laboratory Supplies | EACH | 1590.3 EUR |
Microtube 0.5mL Self-standing w/out Cap |
|||
TUB1086 | Scientific Laboratory Supplies | PK3000 | 110.58 EUR |
Microtube 1.5mL Self-standing w/out Cap |
|||
TUB1090 | Scientific Laboratory Supplies | PK3000 | 118.56 EUR |
Microtube 2mL Self-Stand w/out Cap |
|||
TUB1094 | Scientific Laboratory Supplies | PK3000 | 118.56 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K7052706 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K7052707 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K7052708 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K3480706 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K3480707 | ABM | 1.0 ug DNA | 200.4 EUR |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K3480708 | ABM | 1.0 ug DNA | 200.4 EUR |
Human RRAD And GEM Like GTPase 2 (REM2) ELISA Kit |
|||
abx382769-96tests | Abbexa | 96 tests | 1093.2 EUR |
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
|||
CBA-135 | Cell Biolabs | 96 assays | 985.2 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
|||
CBA-135-5 | Cell Biolabs | 5 x 96 assays | 4027.2 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
|||
CBA-140 | Cell Biolabs | 96 assays | 1027.2 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
|||
CBA-140-5 | Cell Biolabs | 5 x 96 assays | 4179.6 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
Human OAF (Out at first protein homolog) ELISA Kit (CUSTOM) |
|||
ELI-38218h | Lifescience Market | 96 Tests | 988.8 EUR |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
abx122938-100ug | Abbexa | 100 ug | 469.2 EUR |
Mouse GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx390415-96tests | Abbexa | 96 tests | 1093.2 EUR |
Rat GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx391893-96tests | Abbexa | 96 tests | 1093.2 EUR |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
abx237237-100ug | Abbexa | 100 ug | 661.2 EUR |
RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
LV658369 | ABM | 1.0 ug DNA | 616.8 EUR |
RRAD Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV658373 | ABM | 1.0 ug DNA | 616.8 EUR |
RRAD Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV658374 | ABM | 1.0 ug DNA | 616.8 EUR |
Mouse GTP- binding protein RAD, Rrad ELISA KIT |
|||
ELI-14089m | Lifescience Market | 96 Tests | 1038 EUR |
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
CBA-325 | Cell Biolabs | 96 assays | 1027.2 EUR |
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
CBA-325-5 | Cell Biolabs | 5 x 96 assays | 4033.2 EUR |
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
EtB Out Nucleic Acid Staining Solution20,000 x RoomTemperature |
|||
FYD007-200P | Yeastern Biotech | 200 Preps, 1 ml | Ask for price |
Bottle Duran Plastic Coat 1L W/out Cap |
|||
2180554 | Scientific Laboratory Supplies | EACH | 35.34 EUR |
Hettich Swing Out Rotor 8 x 50ml Falcon |
|||
CEN0420 | Scientific Laboratory Supplies | EACH | 874.38 EUR |
Hettich Swing Out Rotor 6 x 50ml Falcon |
|||
CEN0421 | Scientific Laboratory Supplies | EACH | 930.24 EUR |
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric, Trial Size |
|||
CBA-135-T | Cell Biolabs | 24 assays | 518.4 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect 96-Well Cell Transformation Assay (Cell Recovery Compatible, Fluorometric), Trial Size |
|||
CBA-140-T | Cell Biolabs | 24 assays | 547.2 EUR |
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
Collagen-based Cell Contraction Assay |
|||
CBA-201 | Cell Biolabs | 24 assays | 582 EUR |
Description: Cell Biolabs? Collagen-based Contraction Assay Kit provides a simple system to assess cell contractivity in vitro and screen cell contraction mediators. Each kit provides sufficient quantities to perform up to 24 assays in a 24-well plate. The kit can be also used in culturing cells in 3D collagen matrix. |
|||
CytoSelect MTT Cell Proliferation Assay |
|||
CBA-252 | Cell Biolabs | 960 assays | 490.8 EUR |
Description: Cell Biolabs? CytoSelect MTT Cell Proliferation Assay provides a colorimetric format for measuring and monitoring cell proliferation. The kit contains sufficient reagents for the evaluation of 960 assays in 96-well plates or 192 assays in 24-well plates. Cells can be plated and then treated with compounds or agents that affect proliferation. Cells are then detected with the proliferation reagent, which is converted in live cells from the yellow tetrazole MTT to the purple formazan form by a cellular reductase (Figure 1). An increase in cell proliferation is accompanied by an increased signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions. The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues. This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. |
|||
hspCas9 AAVS1 Safe Harbor Knock-in Donor (AAVS1-SA-puro-EF1-hspCas9) |
|||
CAS620A-1 | SBI | 10 ug | 1417.2 EUR |
hspCas9 AAVS1 Safe Harbor Knock-in Donor (AAVS1-SA-puro-EF1-hspCas9) |
|||
CAS620A-KIT | SBI | 1 kit | 2582.4 EUR |
Description: Complete Kit with CAS601A-1 (Cas9 SmartNuclease AAVS1-gRNA Targeting Vector), CAS640PR-1 (Junction PCR Primer Mix to confirm Cas9 integration site), and CAS9-PR-1 (PCR primers to confirm Cas9 expression) |
|||
CytoSelect 24-well Cell Invasion, Fluorometric |
|||
CBA-111 | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with ECM matrix gel (basement membrane), a protein mix isolated from EHS tumor cells. |
|||
CytoSelect 96-well Cell Invasion, Fluorometric |
|||
CBA-112 | Cell Biolabs | 96 assays | 908.4 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect 96-Well Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 96-well plates on a fluorescence plate reader. Inserts are precoated on the top of the membrane with Basement Membrane, an ECM protein mix isolated from EHS tumor cells. |
|||
Radius 24-Well Cell Migration Assay |
|||
CBA-125 | Cell Biolabs | 24 assays | 602.4 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 24-Well Cell Migration Assay |
|||
CBA-125-5 | Cell Biolabs | 5 x 24 assays | 2362.8 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 96-Well Cell Migration Assay |
|||
CBA-126 | Cell Biolabs | 96 assays | 686.4 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 96-Well Cell Migration Assay |
|||
CBA-126-5 | Cell Biolabs | 5 x 96 assays | 2697.6 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 384-Well Cell Migration Assay |
|||
CBA-127 | Cell Biolabs | 384 assays | 721.2 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 384-Well Cell Migration Assay |
|||
CBA-127-5 | Cell Biolabs | 5 x 384 wells | 2802 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
CytoSelect 96-well Cell Transformation Assay |
|||
CBA-130 | Cell Biolabs | 96 assays | 866.4 EUR |
Description: Our CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation) is suitable for measuring cell transformation where no downstream analysis is required. Cells are incubated in a semisolid agar medium for 7-8 days. The cells are then solubilized, lysed and detected using the included fluorescent dye in a fluorometric plate reader. |
|||
CytoSelect 96-well Cell Transformation Assay |
|||
CBA-130-5 | Cell Biolabs | 5 x 96 assays | 3463.2 EUR |
Description: Our CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation) is suitable for measuring cell transformation where no downstream analysis is required. Cells are incubated in a semisolid agar medium for 7-8 days. The cells are then solubilized, lysed and detected using the included fluorescent dye in a fluorometric plate reader. |
|||
CytoSelect Cell Viability and Cytotoxicity Assay |
|||
CBA-240 | Cell Biolabs | 96 assays | 470.4 EUR |
Description: The CytoSelect Cell Viability and Cytotoxicity Assay Kit provides a simple format for monitoring cell viability via metabolic activity. Live cells are detected with either MTT (colorimetric detection) or Calcein AM (fluorometric detection). Dead cells are detected by EthD-1 reagent (fluorometric). All 3 detection reagents are included, along with Saponin (a cell death initiator). Prior to the assay, cells may be treated with compounds or agents that affect cell viability. This kit is suitable for eukaryotic cells, not yeast or bacteria. |
|||
CytoSelect Cell Proliferation Assay Reagent (Fluorometric) |
|||
CBA-250 | Cell Biolabs | 10 mL | 490.8 EUR |
Description: Cell Biolabs? CytoSelect Cell Proliferation Assay Reagent (Fluorometric) provides a fluorometric format for measuring and monitoring cell proliferation. Cells can be plated and then treated with compounds or agents that affect proliferation. Cells are then incubated with the proliferation reagent. Upon entering metabolically active live cells, the non-fluorescent proliferation reagent is converted into a bright red fluorescent form. An increase in cell proliferation is accompanied by increased fluorescent signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions. The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues. This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. The kit contains sufficient reagents for the evaluation of 960 assays in ten 96-well plates or 192 assays in eight 24-well plates. |
|||
CytoSelect BrdU Cell Proliferation ELISA Kit |
|||
CBA-251 | Cell Biolabs | 96 assays | 637.2 EUR |
Description: The CytoSelect BrdU Cell Proliferation ELISA Kit detects BrdU incorporated into cellular DNA during cell proliferation using an anti-BrdU antibody. When cells are incubated in media containing BrdU, the pyrimidine analog is incorporated in place of thymidine into the newly synthesized DNA of proliferating cells. Once the labeling media is removed, the cells are fixed and the DNA is denatured in one step with a fix/denature solution (denaturation of the DNA is necessary to improve the accessibility of the incorporated BrdU for detection). Then an anti-BrdU mouse monoclonal antibody is added followed by an HRP conjugated secondary antibody to detect the incorporated BrdU. The magnitude of the absorbance for the developed color is proportional to the quantity of BrdU incorporated into cells and can be directly correlated to cell proliferation. |
|||
CytoSelect Cell Proliferation Assay Reagent (Colorimetric) |
|||
CBA-253 | Cell Biolabs | 10 mL | 490.8 EUR |
Description: Cell Biolabs? CytoSelect WST-1 Cell Proliferation Assay Reagent provides a colorimetric format for measuring and monitoring cell proliferation. The 10 mL volume is sufficient for the evaluation of 960 assays in ten 96-well plates or 192 assays in eight 24-well plates. Cells can be plated and then treated with compounds or agents that affect proliferation. Cells are then detected with the proliferation reagent, which is converted in live cells from WST-1 to the formazan form in the presence of cellular NADH and an electron mediator. An increase in cell proliferation is accompanied by increased signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions. The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues. This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. |
|||
Radius 48-Well Cell Migration Assay |
|||
CBA-5037 | Cell Biolabs | 48 assays | 622.8 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
Radius 48-Well Cell Migration Assay |
|||
CBA-5037-5 | Cell Biolabs | 5 x 48 assays | 2454 EUR |
Description: The Radius Cell Migration Assay provides a unique alternative to conventional cell migration assays using the Boyden chamber. Unlike Boyden chamber assays which may only be analyzed at endpoint, the Radius assay uses a proprietary cell culture plate containing a carefully-defined biocompatible hydrogel (Radius gel) spot centralized at the bottom of each well. When cells are seeded in the well, they will attach everywhere except on the Radius gel, creating a cell-free zone. Following cell seeding the Radius gel is removed, allowing migratory cells to move across the area and close the gap. |
|||
ROTOR, 6 X 5ML SWING-OUT ROTOR,1/CS |
|||
480138 | CORNING | 1/pk | 645.6 EUR |
Description: Lab Equipment; General Purpose Centrifuges (affliated brand) |
|||
PIPET CONTROLLER - UNIVERSAL POWER SUPPLY IN:100-250V, OUT: |
|||
357489 | CORNING | 1/pk | 69.6 EUR |
Description: Falcon Liquid Handling Equipment; Falcon Pipet Controllers and Accessories |
|||
Rat Out at first protein homolog (OAF) ELISA Kit |
|||
abx391739-96tests | Abbexa | 96 tests | 1093.2 EUR |
Mouse Out at first protein homolog (OAF) ELISA Kit |
|||
abx390101-96tests | Abbexa | 96 tests | 1093.2 EUR |
Chicken Out at first protein homolog, oaf ELISA KIT |
|||
ELI-13285c | Lifescience Market | 96 Tests | 1113.6 EUR |
Rat Out at first protein homolog, Oaf ELISA KIT |
|||
ELI-15146r | Lifescience Market | 96 Tests | 1063.2 EUR |
Eppendorf A-4-38 swing out rotor without buckets |
|||
E5702740004 | Scientific Laboratory Supplies | EACH | 548.34 EUR |
Rack with 7 Pull Out Trays for U535725 Freezer |
|||
FRE6160 | Scientific Laboratory Supplies | EACH | 362.52 EUR |
CytoSelect 24-well Cell Invasion Assay, Colorimetric |
|||
CBA-110 | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with ECM matrix gel (basement membrane), a protein mix isolated from EHS tumor cells. |
|||
CytoSelect 24-well Collagen Cell Invasion, Colorimetric |
|||
CBA-110-COL | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Collagen I. |
|||
CytoSelect 24-well Laminin Cell Invasion, Colorimetric |
|||
CBA-110-LN | Cell Biolabs | 12 assays | 714 EUR |
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with Laminin. |
|||
CytoSelect 384-well Cell Transformation Assay, Fluorometric |
|||
CBA-145 | Cell Biolabs | 384 assays | 1208.4 EUR |
Description: Our CytoSelect 384-Well Cell Transformation Assay uses a modified soft agar 3D matrix to support the formation of colonies by neoplastic cells. Quantitation of cell transformation is performed on a fluorescence plate reader. |
|||
CytoSelect 384-well Cell Transformation Assay, Fluorometric |
|||
CBA-145-5 | Cell Biolabs | 5 x 384 assays | 4681.2 EUR |
Description: Our CytoSelect 384-Well Cell Transformation Assay uses a modified soft agar 3D matrix to support the formation of colonies by neoplastic cells. Quantitation of cell transformation is performed on a fluorescence plate reader. |
|||
CytoSelect 24-Well Cell Co-Culture System |
|||
CBA-160 | Cell Biolabs | 24 assays | 525.6 EUR |
Description: CytoSelect 24-Well Cell Co-Culture System provides a unique platform to monitor direct contact between two cell types in a single well. First, cells are cultured until they form a monolayer around the insert, creating a defined 8 mm cell-free zone. Once the insert is removed, a second cell type may be seeded into the exposed zone. The kit contains proprietary treated inserts and sufficient reagents for the evaluation of 24 samples. The inserts are compatible with most adherent cell types and experimental conditions. |
|||
CytoSelect 24-Well Cell Co-Culture System |
|||
CBA-160-5 | Cell Biolabs | 5 x 24 assays | 2078.4 EUR |
Description: CytoSelect 24-Well Cell Co-Culture System provides a unique platform to monitor direct contact between two cell types in a single well. First, cells are cultured until they form a monolayer around the insert, creating a defined 8 mm cell-free zone. Once the insert is removed, a second cell type may be seeded into the exposed zone. The kit contains proprietary treated inserts and sufficient reagents for the evaluation of 24 samples. The inserts are compatible with most adherent cell types and experimental conditions. |
|||
HIF-1 Alpha Cell Based ELISA Kit |
|||
CBA-281 | Cell Biolabs | 96 assays | 734.4 EUR |
Description: Cell Biolabs? HIF-1 Cell Based ELISA Kit is an immunoassay developed for rapid detection of HIF-1 Alpha in fixed cells. Cells on a microplate are stimulated for HIF-1 Alpha stabilization, fixed, permeabilized, and then neutralized in the well. HIF-1 Alpha is then detected with an anti-HIF-1 alpha antibody followed by an HRP conjugated secondary antibody. Each kit provides sufficient reagents to perform up to a total of 96 assays and can detect HIF-1 Alpha from human, mouse, or rat. |
Independent components associated to poor glycemic management (hemoglobinA1c ≥ 7%) have been being feminine, youthful aged, dwelling within the northeastern area, obtained care type hospitals decrease than regional stage, underneath common well being protection scheme, higher period of diabetes, increased physique mass index stage and absence of hypertension comorbidity.